Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.

Journal of diabetes investigation - 1 Nov 2024

Januszewski Andrzej S, Young Hayden K, Ong Kwok-Leung, Li Liping, O'Connell Rachel L, Lyons Timothy J, Kelly Clare, Zaharieva Dessi P, Sullivan David R, Scott Russell S, Keech Anthony C, Jenkins Alicia J

Abstract excerpt

AIMS/HYPOTHESIS: In diabetes haptoglobin (Hp) 2 vs Hp 1 allelic product is associated with cardiac and renal complications. Few studies report both Hp phenotype and Hp levels. In a Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial substudy we evaluated the Hp phenotype, Hp levels, and fenofibrate effects. MATERIALS AND METHODS: In 480 adults with type 2 diabetes (T2D) the Hp phenotype was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haptoglobins

Share to Hypolipidemic Agents

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 39171747
DOI: 10.1111/jdi.14290
PMCID: PMC11527820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate.PMID 39171747Read ↗

Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.Semantic proximity Read ↗

Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.Semantic proximity Read ↗

Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Semantic proximity Read ↗

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.Semantic proximity Read ↗

The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.Semantic proximity Read ↗

Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.Semantic proximity Read ↗

The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study.Semantic proximity Read ↗

The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.Semantic proximity Read ↗

Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.Semantic proximity Read ↗

Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Semantic proximity Read ↗

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.Semantic proximity Read ↗

Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.